Shanghai RAAS Blood Products Co., Ltd. (SHE:002252)
China · Delayed Price · Currency is CNY 5.82
-0.03 (-0.51%)
Mar 30, 2026, 12:14 PM CST
SHE:002252 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 1,577 | 2,193 | 1,779 | 1,880 | 1,295 |
Depreciation & Amortization | 225.85 | 207.39 | 163 | 184.98 | 159.27 |
Other Amortization | 15.65 | 10.05 | 9.5 | 9.94 | 9.55 |
Loss (Gain) From Sale of Assets | -21.16 | 1.61 | 0.01 | -0.23 | 1.35 |
Asset Writedown & Restructuring Costs | 92.79 | 13.23 | 4.31 | 199.5 | 370.45 |
Loss (Gain) From Sale of Investments | -352.86 | -513.51 | 196.89 | -430.77 | 42.76 |
Stock-Based Compensation | 19.8 | 53.78 | 21.61 | - | - |
Provision & Write-off of Bad Debts | 20.41 | 43.64 | -5.22 | 16.38 | -10.83 |
Other Operating Activities | 33.83 | -88.14 | -89.3 | -94.55 | -435.77 |
Change in Accounts Receivable | -387.33 | -1,229 | 163.23 | -286.97 | -75.16 |
Change in Inventory | -757.89 | -638.98 | -417.74 | -106.32 | -1,014 |
Change in Accounts Payable | -765.81 | -542.72 | 449.23 | 333.94 | 961.09 |
Operating Cash Flow | -328.69 | -482.06 | 2,278 | 1,726 | 1,294 |
Operating Cash Flow Growth | - | - | 32.01% | 33.35% | 10.71% |
Capital Expenditures | -384.82 | -407.15 | -450.8 | -225.73 | -204.61 |
Sale of Property, Plant & Equipment | 3.19 | 0.33 | 2.33 | 2.24 | 3.19 |
Cash Acquisitions | -3,704 | -34 | -440.69 | - | - |
Investment in Securities | 1,828 | -775.21 | 141.72 | -946.68 | -609.51 |
Other Investing Activities | 5.42 | 300.11 | 76.84 | 39.97 | 80.11 |
Investing Cash Flow | -2,252 | -915.92 | -670.59 | -1,130 | -730.82 |
Long-Term Debt Issued | 3,660 | - | - | - | - |
Total Debt Issued | 3,660 | - | - | - | - |
Short-Term Debt Repaid | - | - | - | - | -7.74 |
Long-Term Debt Repaid | -301.56 | -4.65 | -2.04 | -5.73 | -4.21 |
Total Debt Repaid | -301.56 | -4.65 | -2.04 | -5.73 | -11.95 |
Net Debt Issued (Repaid) | 3,358 | -4.65 | -2.04 | -5.73 | -11.95 |
Issuance of Common Stock | - | 15.57 | 113.17 | - | - |
Repurchase of Common Stock | -478.01 | -2.27 | -1,000 | - | - |
Common Dividends Paid | -258.58 | -439.85 | -202.22 | -188.74 | -168.52 |
Other Financing Activities | -54.5 | -33.2 | -43.13 | 1.09 | 1.19 |
Financing Cash Flow | 2,567 | -464.41 | -1,134 | -193.38 | -179.28 |
Foreign Exchange Rate Adjustments | 16.79 | 1.32 | -3.31 | 11.75 | -2.26 |
Net Cash Flow | 3.26 | -1,861 | 469.77 | 413.78 | 381.66 |
Free Cash Flow | -713.52 | -889.2 | 1,827 | 1,500 | 1,089 |
Free Cash Flow Growth | - | - | 21.82% | 37.68% | 18.79% |
Free Cash Flow Margin | -9.71% | -10.88% | 22.94% | 22.84% | 25.41% |
Free Cash Flow Per Share | -0.11 | -0.13 | 0.28 | 0.22 | 0.16 |
Cash Interest Paid | - | - | - | - | 0.03 |
Cash Income Tax Paid | 621.13 | 825.58 | 644.74 | 593.92 | 339.12 |
Levered Free Cash Flow | -1,055 | -1,223 | 1,594 | 1,180 | 748.69 |
Unlevered Free Cash Flow | -1,027 | -1,223 | 1,594 | 1,180 | 748.99 |
Change in Working Capital | -1,940 | -2,403 | 197.6 | -39.73 | -137.29 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.